Can antihypertensive medication interfere with the vicious cycle between hypertension and vascular calcification?

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pharmacology

Background:

• Vascular calcification involves abnormal calcium deposition in arteries, distinct from bone mineralization.
• Two primary forms, intimal and medial calcification, have different distributions and clinical significance.
• A complex relationship exists between hypertension and vascular calcification, potentially a two-way street.

Purpose of the Study:

• To review current data on the impact of antihypertensive medications on vascular calcification.
• To explore how these medications might interrupt the cycle of hypertension and vascular calcium buildup.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies investigating the effects of various antihypertensive drug classes on vascular calcification markers.
• Synthesis of data on the clinical implications and potential therapeutic benefits.

Main Results:

• Hypertension is a known contributor to vascular calcification.
• Medial calcification, in particular, can exacerbate arterial stiffness and worsen hypertension.
• Several classes of antihypertensive drugs show potential to influence vascular calcification processes.

Conclusions:

• The interplay between hypertension and vascular calcification is complex and not fully understood.
• Antihypertensive medications represent a potential therapeutic avenue to modulate vascular calcification.
• Further research is needed to clarify the clinical value of targeting vascular calcification with these drugs.